Electra Therapeutics Q3 EPS $(3.47) Misses $(2.72) Estimate
Benzinga Newsdesk 17 hours ago
NewsEarningsEarnings Misses
Electra Therapeutics (NASDAQ:ETRA) reported quarterly losses of $(3.47) per share which missed the analyst consensus estimate of $(2.72) by 27.57 percent. This is a 99.44 percent increase over losses of $(616.86) per
Electra Therapeutics (NASDAQ:ETRA) reported quarterly losses of $(3.47) per share which missed the analyst consensus estimate of $(2.72) by 27.57 percent. This is a 99.44 percent increase over losses of $(616.86) per share from the same period last year.